At this time, there are insufficient data to recommend for or against prostate cancer testing in men at average risk of developing the disease.
At this time, there are insufficient data to recommend for or against prostate cancer testing in men at average risk of developing the disease.
The American Cancer Society recommends that beginning at age 50, the PSA blood test (which detects a protein made by the prostate called prostate-specific antigen) and the digital rectal examination should be offered to men at average risk. Individuals at high risk of developing prostate cancer (African Americans or men with a strong family history) should begin screening at age 45. All men should be given information about the benefits and limitations of testing so they can make informed decisions.